Epigral

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE071N01016
  • NSEID: EPIGRAL
  • BSEID: 543332
INR
883.50
14.45 (1.66%)
BSENSE

Apr 02

BSE+NSE Vol: 68.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "883.50",
    "chg": 14.45,
    "chgp": "1.66%",
    "dir": 1,
    "prev_price": "869.05",
    "mcapval": "3,659.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE071N01016",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "68.59 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd Gains 5.26%: Key Market and Sector Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-gains-526-key-market-and-sector-factors-driving-the-week-3931783",
        "imagepath": "",
        "date": "2026-04-04 12:00:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Mar 30:</strong> New 52-week low at Rs.806.2 amid sector and market downturn</p>\n                    <p><strong>Apr 1:</strong> Intraday high reached Rs.866.2 with a 7.09% surge</p>\n                    <p><strong>Apr 2:</strong> Continued gains with a 1.56% rise to Rs.883.05</p>\n                    <p><strong>Apr 3:</strong> Week closes at Rs.883.05, up 5.26% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.838.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.883.05</..."
      },
      {
        "title": "Epigral Ltd Surges 7.09% to Day's High of Rs 866.2 — Outperforms Specialty Chemicals Sector by 2.36 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-709-surge-amid-sector-gains-3929031",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/EpigralLtd_priceRelatedfactors_3929031.png",
        "date": "2026-04-01 11:46:57",
        "description": "The Sensex declined by 2.20% on 1 Apr 2026, while Epigral Ltd surged 7.09%, marking a 4.89-percentage-point outperformance over the benchmark. This sharp intraday gain, reaching a high of Rs 866.2, stands out as a stock-specific event amid a broadly weak market environment."
      },
      {
        "title": "Epigral Ltd Falls to 52-Week Low of Rs 806.2 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-stock-falls-to-52-week-low-of-rs8062-amid-sector-and-market-downturn-3925797",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_priceRelatedfactors_3925797.png",
        "date": "2026-03-30 15:48:35",
        "description": ""
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-3922646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_mojoScore_3922646.png",
        "date": "2026-03-29 10:10:37",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Markets Rally, But Epigral Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-stock-falls-to-52-week-low-of-rs822-amid-sector-and-market-downturn-3908115",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_priceRelatedfactors_3908115.png",
        "date": "2026-03-23 13:54:19",
        "description": "Despite a broader market rally, Epigral Ltd has plunged to a fresh 52-week low of Rs 822 on 23 Mar 2026, marking a steep 57.05% decline over the past year and underscoring persistent headwinds unique to the stock."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-3898243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_mojoScore_3898243.png",
        "date": "2026-03-18 10:11:11",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Falls 3.01% Amid 52-Week Low and Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-falls-301-amid-52-week-low-and-market-pressure-3878119",
        "imagepath": "",
        "date": "2026-03-07 12:02:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> New 52-week low at Rs.822.05 amid sustained downtrend</p>\n                    <p><strong>2 Mar:</strong> Significant gap down opening of 7.93%</p>\n                    <p><strong>4 Mar:</strong> Continued decline with Rs.857.00 close (-1.58%)</p>\n                    <p><strong>6 Mar:</strong> Week closes at Rs.865.95 with a modest 1.06% gain</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.870.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.865.95</div><div class=\"..."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-3877773",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_mojoScore_3877773.png",
        "date": "2026-03-07 10:10:38",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Opens with Significant Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-opens-with-significant-gap-down-amid-market-concerns-3865256",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/EpigralLtd_gapdown_3865256.png",
        "date": "2026-03-02 13:34:28",
        "description": "Epigral Ltd, a specialty chemicals company, opened the trading session with a pronounced gap down, reflecting heightened market concerns following a series of negative performance indicators and a downgrade in its mojo grade. The stock’s opening price plunged by 7.93%, marking a fresh 52-week low and continuing a downward trend that has persisted over the past week."
      }
    ],
    "total": 600,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>25%</strong> dividend, ex-date: 07 Feb 25",
          "dt": "2025-02-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Epigral Ltd Gains 5.26%: Key Market and Sector Factors Driving the Week

2026-04-04 12:00:46

Key Events This Week

Mar 30: New 52-week low at Rs.806.2 amid sector and market downturn

Apr 1: Intraday high reached Rs.866.2 with a 7.09% surge

Apr 2: Continued gains with a 1.56% rise to Rs.883.05

Apr 3: Week closes at Rs.883.05, up 5.26% for the week

stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Epigral Ltd has declared 25% dividend, ex-date: 07 Feb 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available